Single- and Repeat-Dose Nonclinical Data for PGN-EDO51 Demonstrated Favorable Pharmacology and Safety Profiles for the Treatment of DMD
Nonclinical Data for PGN-EDODM1 Demonstrated Nuclear Delivery, Mechanistic and Meaningful Activity for the Potential Treatment of DM1
Nonclinical in vitro and in vivo data demonstrated low immunogenicity risk and favorable of PGN-EDO51 for the treatment of DMD
